Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talampanel in Amyotrophic Lateral Sclerosis (ALS)
2008-002062-62Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Talampanel 50 mg TID with Placebo (2 arms). Started Jun 2008; status: completed.
02
Drugs
talampanel
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2008-002062-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002062-62.